Spire Wealth Management »

Centessa Pharmaceuticals shares owned by Spire Wealth Management

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by Spire Wealth Management from 13F filings

Historical chart of Spire Wealth Management investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by Spire Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by Spire Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $791 70 11.30
2023-12-31 $567 70 8.10

More positions owned by Spire Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Vanguard World Fds Inf Tech Etf (VGT)
Amazon (AMZN)
Spdr S P 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Select Sector Spdr Tr Financial (XLF)
Ishares Tr Core Us Aggbd Et (AGG)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Ishares Tr Core S&p Mcp Etf (IJH)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Spire Wealth Management

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
BVF
EcoR1 Capital
Vida Ventures Advisors
T. Rowe Price Associates
Octagon Capital Advisors
Point72 Asset Management
Franklin Resources
Artal Group
Tanager Wealth Management
Cormorant Asset Management
Kynam Capital Management
TD Asset Management
Citadel Advisors
Millennium Management

View all funds holding Centessa Pharmaceuticals